Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Barclays Maintains Overweight on Mimecast, Raises Price Target to $75

Barclays analyst Saket Kalia maintains Mimecast (NASDAQ:MIME) with a Overweight and raises the price target from $70 to $75.

byBenzinga Newsdesk

October 13, 2021

1 minute read

Barclays analyst Saket Kalia maintains Mimecast (NASDAQ:MIME) with a Overweight and raises the price target from $70 to $75.

Wells Fargo Maintains Equal-Weight on Bakkt Hldgs, Lowers Price Target to $2

By Benzinga Newsdesk

Today, 3:07 AM

Wells Fargo analyst Jeff Cantwell maintains Bakkt Hldgs (NYSE:BKKT) with a Equal-Weight and lowers the price target from $2.5 to $2.

BKKT

Analyst Ratings

5 Analysts Have This to Say About Liberty Energy

By Benzinga Insights

Today, 3:07 AM

Liberty Energy (NYSE:LBRT) has observed the following analyst ratings within the last quarter:

LBRT

Ryder Renews $1.4B Revolving Credit Facility

By Akanksha Bakshi

Today, 3:07 AM

Ryder System, Inc. (NYSE:R) executed a new $1.4 billion five-year global revolving credit facility that will expire on December 14, 2026,…

Sonoma Pharma, MicroSafe Report Nanocyn Disinfectant, Sanitzer Has Been Approved By Australia Therapeutic Goods Admin.

By Benzinga Newsdesk

Today, 3:07 AM

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care,

SNOA

Barclays Maintains Overweight on Mimecast, Raises Price Target to $75

Related Posts

Wells Fargo Maintains Equal-Weight on Bakkt Hldgs, Lowers Price Target to $2

5 Analysts Have This to Say About Liberty Energy

Ryder Renews $1.4B Revolving Credit Facility

Sonoma Pharma, MicroSafe Report Nanocyn Disinfectant, Sanitzer Has Been Approved By Australia Therapeutic Goods Admin.